Orthofix International N.V. (OFIX) Stake Held by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky held its stake in Orthofix International N.V. (NASDAQ:OFIX) during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 26,831 shares of the medical device company’s stock at the end of the second quarter. Teachers Retirement System of The State of Kentucky owned 0.15% of Orthofix International N.V. worth $1,247,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Pinebridge Investments L.P. increased its holdings in Orthofix International N.V. by 2.3% during the 2nd quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 53 shares during the period. Mason Street Advisors LLC purchased a new position in Orthofix International N.V. during the 1st quarter valued at about $159,000. State of Alaska Department of Revenue increased its holdings in Orthofix International N.V. by 79.3% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock valued at $165,000 after purchasing an additional 1,571 shares during the period. Quantbot Technologies LP purchased a new position in Orthofix International N.V. during the 1st quarter valued at about $175,000. Finally, BNP Paribas Arbitrage SA increased its holdings in Orthofix International N.V. by 68.9% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock valued at $178,000 after purchasing an additional 1,900 shares during the period. Institutional investors own 94.40% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Orthofix International N.V. (OFIX) Stake Held by Teachers Retirement System of The State of Kentucky” was originally published by Transcript Daily and is owned by of Transcript Daily. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://transcriptdaily.com/2017/10/08/orthofix-international-n-v-ofix-stake-held-by-teachers-retirement-system-of-the-state-of-kentucky.html.

Orthofix International N.V. (OFIX) opened at 50.68 on Friday. Orthofix International N.V. has a one year low of $32.51 and a one year high of $51.09. The company’s 50-day moving average price is $48.66 and its 200-day moving average price is $44.16. The stock has a market cap of $920.86 million, a P/E ratio of 118.69 and a beta of 0.20.

Orthofix International N.V. (NASDAQ:OFIX) last announced its quarterly earnings data on Monday, August 7th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.01. The business had revenue of $108.90 million during the quarter, compared to the consensus estimate of $102.94 million. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.41 earnings per share. Analysts forecast that Orthofix International N.V. will post $1.56 EPS for the current fiscal year.

A number of brokerages recently issued reports on OFIX. Langenberg & Company restated a “buy” rating and set a $53.25 price target on shares of Orthofix International N.V. in a report on Wednesday, June 14th. Jefferies Group LLC restated a “buy” rating and set a $55.00 price target (up previously from $50.00) on shares of Orthofix International N.V. in a report on Thursday, August 10th. BidaskClub downgraded Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. BTIG Research began coverage on Orthofix International N.V. in a report on Wednesday, June 21st. They set a “buy” rating and a $52.00 price target on the stock. Finally, Zacks Investment Research upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a report on Thursday, August 10th. Seven investment analysts have rated the stock with a buy rating, Orthofix International N.V. currently has a consensus rating of “Buy” and a consensus target price of $52.75.

In other news, insider Raymond Fujikawa sold 6,364 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $47.06, for a total transaction of $299,489.84. Following the transaction, the insider now directly owns 31,084 shares of the company’s stock, valued at $1,462,813.04. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Bradley V. Niemann sold 6,956 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $49.44, for a total transaction of $343,904.64. Following the transaction, the insider now directly owns 40,178 shares in the company, valued at $1,986,400.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 23,406 shares of company stock worth $1,138,531. Corporate insiders own 5.60% of the company’s stock.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply